Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelomonocytic, Chronic

Explore clinical trials studying Leukemia, Myelomonocytic, Chronic. Study availability and eligibility vary by location and protocol.

416 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelomonocytic, Chronic trial results

Completed

Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes

NCT00352001

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
  • Cleveland Clinic Taussig Cancer Instititute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

NCT00451048

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
Locations
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • London Regional Cancer Program London, Ontario, Canada
  • Odette Cancer Centre- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
  • University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details
Completed

Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

NCT02201329

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Boehringer Ingelheim Investigational Site Aichi, Nagoya, Japan
  • Boehringer Ingelheim Investigational Site Gunma, Maebashi, Japan
  • Boehringer Ingelheim Investigational Site Nagasaki, Nagasaki, Japan
  • Boehringer Ingelheim Investigational Site Tokyo, Sinagawa-ku, Japan
View Trial Details

Related conditions